SCHEMBL4707642

SCHEMBL4707642

Nc1nc(Cl)c(Br)c(-c2cc(Cl)ccc2O)n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AGPAT2 O15120 2/20 0.47
CDK9 P50750 4/20 0.45
NPC1 O15118 4/20 0.45
SMN1; SMN2 Q16637 3/20 0.45
KDM4E B2RXH2 2/20 0.45
LMNA P02545 2/20 0.45
CASP3 P42574 2/20 0.45
RAB9A P51151 2/20 0.45
SENP7 Q9BQF6 2/20 0.45
NFKB1 P19838 1/20 0.45
CDK5 Q00535 1/20 0.45
NFKB2 Q00653 1/20 0.45
RELA Q04206 1/20 0.45
CDK5R1 Q15078 1/20 0.45
SENP8 Q96LD8 1/20 0.45
SENP6 Q9GZR1 1/20 0.45
ALDH1A1 P00352 2/20 0.41
HPGD P15428 2/20 0.41
MAPK1 P28482 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4738127 0.88 AGPAT2 (0.48) AGPAT2NPC1SMN1; SMN2LMNARAB9A
SCHEMBL29287111 0.79 ADORA2A (0.39) CDK9CDK5MAPK1HSP90AA1HTR2B
SCHEMBL4286785 0.78 RECQL (0.53) AGPAT2NPC1SMN1; SMN2KDM4ELMNA
SCHEMBL17271571 0.74 MGAM (0.45) AGPAT2CDK9NPC1SMN1; SMN2KDM4E
SCHEMBL28302056 0.74 ADORA2A (0.50) NPC1SMN1; SMN2KDM4ELMNARAB9A
SCHEMBL2489752 0.74 NPC1 (0.68) AGPAT2CDK9NPC1SMN1; SMN2KDM4E
SCHEMBL4291570 0.70 HSP90AA1 (0.66) AGPAT2CDK9NPC1SMN1; SMN2KDM4E
SCHEMBL21801683 0.70 ADORA2A (0.51) NPC1ALDH1A1MEN1MAPTKMT2A
SCHEMBL17271570 0.70 CDC7 (0.48) AGPAT2CDK9MAPTPIM1IDO1
SCHEMBL21583424 0.69 ADORA2A (0.54) KDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1991550-A1 AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS Cellzome Limited (GB) 2008-11-19 EP disclosed
EP-1860109-A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders Cellzome (UK) Ltd. (GB) 2007-11-28 EP disclosed
EP-1860109-A1 Azetidine amino pyrimidine compounds for the treatment of inflammatory disorders Cellzome (UK) Ltd. (GB) 2007-11-28 EP disclosed
EP-1860108-A1 Enantiomers of Amino Pyrimidine compounds for the treatment of inflammatory disorders Cellzome (UK) Ltd. (GB) 2007-11-28 EP disclosed
EP-1860108-A1 Enantiomers of Amino Pyrimidine compounds for the treatment of inflammatory disorders Cellzome (UK) Ltd. (GB) 2007-11-28 EP disclosed
EP-1829879-A1 Amino pyrimidine compounds for the treatment of inflammatory disorders Cellzome (UK) Ltd. (GB) 2007-09-05 EP disclosed
EP-1829879-A1 Amino pyrimidine compounds for the treatment of inflammatory disorders Cellzome (UK) Ltd. (GB) 2007-09-05 EP disclosed
WO-2007090854-A1 AZETIDINE AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME (UK) LTD. (GB) 2007-08-16 WO disclosed
WO-2007090853-A1 ENANTIOMERS OF AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME (UK) LTD. (GB) 2007-08-16 WO disclosed
WO-2007090853-A1 ENANTIOMERS OF AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME (UK) LTD. (GB) 2007-08-16 WO disclosed
WO-2007090852-A1 AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME LIMITED (GB) 2007-08-16 WO disclosed
WO-2007090852-A1 AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME LIMITED (GB) 2007-08-16 WO disclosed
WO-2007090854-A1 AZETIDINE AMINO PYRIMIDINE COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS CELLZOME (UK) LTD. (GB) 2007-08-16 WO disclosed